by Attorney-at-Law Martin Arendts, M.B.L.-HSG
At the end of November 2025, a “voluntary public purchase offer” to the shareholders of Pharma SGP Holding SE (WKN A2P4LJ, ISIN: DE000A2P4LJ5) was published in the Federal Gazette/"Bundesanzeiger" (and thus with a completely official stamp). The offer is for EUR 34.30 per PharmaSGP share, significantly more than the cash compensation of EUR 30.64 per share offered for the upcoming squeeze-out and higher than the current stock market prices.
In addition to the questionable economic viability of the offer, the unusual email address “mail.de” is also cause for concern. The offer allegedly comes from Brockhaus Private Equity GmbH, which has, however, clearly denied this. It is therefore likely to be a case of identity theft (a fairly common scam in such cases).
There have been a number of similar dubious purchase offers recently. In some cases, attempts are made to persuade interested parties to make further purchases and payments. In other cases, confidential data (bank details and securities account numbers) is also obtained.
https://spruchverfahren.blogspot.com/2025/12/unserioses-kaufangebot-fur-aktien-der.html
No comments:
Post a Comment